BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 32826455)

  • 1. MicroRNA-145 suppresses uveal melanoma angiogenesis and growth by targeting neuroblastoma RAS viral oncogene homolog and vascular endothelial growth factor.
    Yang JY; Li Y; Wang Q; Zhou WJ; Yan YN; Wei WB
    Chin Med J (Engl); 2020 Aug; 133(16):1922-1929. PubMed ID: 32826455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of microRNA-130a represses uveal melanoma cell migration and invasion through inactivation of the Wnt/β-catenin signaling pathway by downregulating USP6.
    Wu S; Han M; Zhang C
    Cancer Gene Ther; 2022 Jul; 29(7):930-939. PubMed ID: 34522027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-224-5p inhibits proliferation, migration, and invasion by targeting PIK3R3/AKT3 in uveal melanoma.
    Li J; Liu X; Li C; Wang W
    J Cell Biochem; 2019 Aug; 120(8):12412-12421. PubMed ID: 30825222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA 145 may play an important role in uveal melanoma cell growth by potentially targeting insulin receptor substrate-1.
    Li Y; Huang Q; Shi X; Jin X; Shen L; Xu X; Wei W
    Chin Med J (Engl); 2014; 127(8):1410-6. PubMed ID: 24762580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-34b/c suppresses uveal melanoma cell proliferation and migration through multiple targets.
    Dong F; Lou D
    Mol Vis; 2012; 18():537-46. PubMed ID: 22419847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HMGA1 exacerbates tumor progression by activating miR-222 through PI3K/Akt/MMP-9 signaling pathway in uveal melanoma.
    Cheng Y; Cheng T; Zhao Y; Qu Y
    Cell Signal; 2019 Nov; 63():109386. PubMed ID: 31394192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-124 governs glioma growth and angiogenesis and enhances chemosensitivity by targeting R-Ras and N-Ras.
    Shi Z; Chen Q; Li C; Wang L; Qian X; Jiang C; Liu X; Wang X; Li H; Kang C; Jiang T; Liu LZ; You Y; Liu N; Jiang BH
    Neuro Oncol; 2014 Oct; 16(10):1341-53. PubMed ID: 24861879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-137 targets EZH2 to exert suppressive functions in uveal melanoma via regulation of Wnt/β-catenin signaling and epithelial-to-mesenchymal transition.
    Zhang J; Liu G; Jin H; Li X; Li N; Yin Q; Hu R
    J BUON; 2021; 26(1):173-181. PubMed ID: 33721449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-inducible factor 1 upregulation of both VEGF and ANGPTL4 is required to promote the angiogenic phenotype in uveal melanoma.
    Hu K; Babapoor-Farrokhran S; Rodrigues M; Deshpande M; Puchner B; Kashiwabuchi F; Hassan SJ; Asnaghi L; Handa JT; Merbs S; Eberhart CG; Semenza GL; Montaner S; Sodhi A
    Oncotarget; 2016 Feb; 7(7):7816-28. PubMed ID: 26761211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of microRNA-21 in uveal melanoma cell invasion and metastasis by regulating p53 and its downstream protein.
    Wang YC; Yang X; Wei WB; Xu XL
    Int J Ophthalmol; 2018; 11(8):1258-1268. PubMed ID: 30140627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repression of microRNA-21 inhibits retinal vascular endothelial cell growth and angiogenesis via PTEN dependent-PI3K/Akt/VEGF signaling pathway in diabetic retinopathy.
    Lu JM; Zhang ZZ; Ma X; Fang SF; Qin XH
    Exp Eye Res; 2020 Jan; 190():107886. PubMed ID: 31759996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Luteolin Suppresses Three Angiogenesis Modes and Cell Interaction in Uveal Melanoma
    Chen YF; Wu S; Li X; Chen M; Liao HF
    Curr Eye Res; 2022 Dec; 47(12):1590-1599. PubMed ID: 36214596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-15a and miR-16 affect the angiogenesis of multiple myeloma by targeting VEGF.
    Sun CY; She XM; Qin Y; Chu ZB; Chen L; Ai LS; Zhang L; Hu Y
    Carcinogenesis; 2013 Feb; 34(2):426-35. PubMed ID: 23104180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma.
    Chen HX; Xu XX; Tan BZ; Zhang Z; Zhou XD
    Cell Physiol Biochem; 2017; 41(3):933-946. PubMed ID: 28222438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long Noncoding RNA PVT1 Silencing Prevents the Development of Uveal Melanoma by Impairing MicroRNA-17-3p-Dependent MDM2 Upregulation.
    Wu S; Chen H; Han N; Zhang C; Yan H
    Invest Ophthalmol Vis Sci; 2019 Nov; 60(14):4904-4914. PubMed ID: 31770435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-4739 inhibits the malignant behavior of esophageal squamous cell carcinoma cells via the homeobox C10/vascular endothelial growth factor A/phosphatidylinositol 3-kinase/AKT pathway.
    Wu K; Liu Z; Dong C; Gu S; Li L; Wang W; Zhou Y
    Bioengineered; 2022 Jun; 13(6):14066-14079. PubMed ID: 35730500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met.
    Yan D; Zhou X; Chen X; Hu DN; Dong XD; Wang J; Lu F; Tu L; Qu J
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1559-65. PubMed ID: 19029026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-199a-3p inhibits angiogenesis by targeting the VEGF/PI3K/AKT signalling pathway in an in vitro model of diabetic retinopathy.
    Wang L; Liu WX; Huang XG
    Exp Mol Pathol; 2020 Oct; 116():104488. PubMed ID: 32622012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor expression and inhibition in uveal melanoma cell lines.
    Logan P; Burnier J; Burnier MN
    Ecancermedicalscience; 2013; 7():336. PubMed ID: 23914254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.